Related Experiment Video
Updated: Aug 15, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Induction of cytokines in mice with parainfluenza pneumonia
X Y Mo1, S R Sarawar, P C Doherty
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Abstract:
The possible involvement of cytokines in the acute viral pneumonia induced by the murine parainfluenza type 1 virus, Sendai virus, was studied. Cytokine profiles for both the respiratory tract and the draining mediastinal lymph node (MLN) of virus-infected C57BL/6J mice were quantified by using the single-cell cytokine (ELISPOT) assay with freshly isolated cell populations and enzyme-linked immunosorbent assay for lung lavage fluids and culture supernatants. Maximal levels of interleukin 2 (IL-2), gamma interferon (IFN-gamma), tumor necrosis factor, IL-6, and IL-10 were detected at the inflammatory site 7 to 10 days after infection, about the time that virus is cleared from the lung. The frequencies of cells producing IL-2, IL-4, IL-6, IL-10, IFN-gamma, and tumor necrosis factor were much higher for the bronchoalveolar lavage (BAL) cell population than for the MLN cell population. Cytokine production after in vitro restimulation of MLN cells was dominated by IL-2 and IFN-gamma, with low levels of IL-10 and IL-6 also being present. Most of the cytokine was produced by the CD4+ cells, although the CD8+ subset was also involved. No IL-4 was found in the BAL fluid or in culture supernatants from restimulated BAL or MLN cells, although a high frequency of IL-4-producing cells was demonstrated in the BAL population by ELISPOT analysis.
Insights
Cytokines like IL-2 and IFN-gamma are crucial in clearing Sendai virus pneumonia in mice. Immune cells in the lungs produce higher cytokine levels than lymph nodes during viral clearance.
Area of Science:
- Immunology
- Virology
- Respiratory Medicine
Background:
- Acute viral pneumonia, often caused by respiratory viruses, triggers significant immune responses.
- Cytokines play a critical role in modulating the host's immune defense against viral infections.
- Understanding cytokine dynamics is key to developing effective treatments for viral lung diseases.
Purpose of the Study:
- To investigate the role of cytokines in acute viral pneumonia induced by Sendai virus in a mouse model.
- To quantify and compare cytokine profiles in the respiratory tract and draining lymph nodes.
- To identify specific immune cells responsible for cytokine production during viral clearance.
Main Methods:
- Utilized C57BL/6J mice infected with Sendai virus to model acute viral pneumonia.
- Employed single-cell cytokine (ELISPOT) assay and enzyme-linked immunosorbent assay (ELISA) for cytokine quantification.
- Analyzed cytokine levels in bronchoalveolar lavage (BAL) fluid, mediastinal lymph node (MLN) cells, and lung lavage fluids.
Main Results:
- Maximal levels of IL-2, IFN-gamma, TNF, IL-6, and IL-10 were detected 7-10 days post-infection, coinciding with viral clearance.
- Bronchoalveolar lavage cells showed significantly higher frequencies of cytokine-producing cells (IL-2, IL-4, IL-6, IL-10, IFN-gamma, TNF) compared to MLN cells.
- Restimulated MLN cells primarily produced IL-2 and IFN-gamma, with some IL-10 and IL-6; CD4+ cells were the main producers, with CD8+ cells also involved.
Conclusions:
- Cytokine production, particularly IL-2 and IFN-gamma, is vital for resolving Sendai virus-induced pneumonia in mice.
- Lung-resident immune cells are the primary source of cytokines during the acute phase of viral pneumonia.
- Despite low extracellular levels, IL-4-producing cells are abundant in the BAL, suggesting complex local immune regulation.
More Related Videos
07:07Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022